What is Multi-State Operator (MSO)?

A Multi-State Operator (MSO) is a cannabis company that holds licenses and operates in multiple US states. MSOs are typically vertically integrated, meaning they control the entire supply chain from cultivation and processing to distribution and retail dispensary operations. The largest MSOs, including companies like Curaleaf, Green Thumb Industries, Trulieve, and Verano, operate across 10 or more states and generate hundreds of millions to billions of dollars in annual revenue.

The MSO business model emerged from the state-by-state nature of US cannabis legalization. Because cannabis remains federally illegal, there is no interstate commerce, and each state operates as an independent market with its own licensing, regulatory, and tax frameworks. MSOs build scale by acquiring or winning licenses in multiple states, replicating their operational playbooks, and creating brand recognition across markets.

MSOs face unique challenges compared to other cannabis business models. They must navigate different regulatory environments in each state, manage complex multi-state supply chains without crossing state lines with product, and contend with the 280E tax burden that dramatically reduces profitability. Additionally, federal illegality prevents MSOs from listing on major US stock exchanges like NASDAQ or NYSE, forcing most to trade on the Canadian Securities Exchange (CSE) or US OTC markets.

Despite these challenges, MSOs are widely considered the most attractive segment of the US cannabis market. They benefit from limited license markets that create barriers to entry, first-mover advantages in new states, and operational scale that smaller operators cannot match. If federal legalization or comprehensive reform occurs, MSOs are positioned to be the dominant players, which is why they command the largest market capitalizations in the cannabis sector.

MSOs are the backbone of the legal US cannabis market and represent the majority of institutional cannabis investment. The top five MSOs by revenue collectively generate over $5 billion in annual sales and operate thousands of dispensaries across the country. Their scale advantages in procurement, branding, and operational efficiency make them formidable competitors that smaller operators struggle to match.

For investors, MSOs offer the most direct exposure to the massive US cannabis market, which is estimated to reach $40-50 billion in legal sales. However, MSO investing comes with unique complexities: most trade on Canadian exchanges or US OTC markets, face 280E tax burdens, cannot access traditional banking, and operate in a legally uncertain federal environment. Despite these challenges, the risk-reward profile of well-capitalized MSOs at reasonable valuations continues to attract both retail and institutional investors.